Update on newborn screening.

Area of Science:

• Medical Genetics
• Public Health
• Pediatrics

Background:

• Newborn screening began in the 1960s with phenylketonuria (PKU) testing.
• Current newborn screening panels encompass over 30 genetic and metabolic disorders.
• The scope of newborn screening has significantly evolved over the decades.

Purpose of the Study:

• To provide an updated overview of newborn screening practices.
• To discuss the critical aspects of managing abnormal newborn screening results.
• To examine the inherent limitations and ethical dimensions of widespread newborn screening.

Main Methods:

• Literature review of current newborn screening guidelines and practices.
• Analysis of follow-up protocols for infants with positive screening results.
• Discussion of ethical frameworks relevant to genetic screening in newborns.

Main Results:

• Newborn screening now identifies a broad spectrum of conditions beyond PKU.
• Effective follow-up strategies are crucial for positive newborn screening outcomes.
• Screening limitations include false positives/negatives and the identification of conditions with uncertain clinical significance.

Conclusions:

• Expanded newborn screening offers significant public health benefits but requires careful management.
• Addressing the limitations and ethical questions is essential for responsible implementation.
• Ongoing evaluation and adaptation of newborn screening programs are necessary.